Molecular mechanisms of curcumin action: signal transduction
/in Curcuma, International Publications /von 2013-01-10 / Biofactors 2013 Jan-Feb;39(1):27-36Curcumin in various cancers
/in Curcuma, International Publications /von 2013-01-10 / Biofactors 2013 Jan-Feb;39(1):56-68Oncolytic virus therapy for cancer: the first wave of translational clinical trials
/in International Publications, Newcastle Disease Virus /von 2013-01-10 / Transl Res 2013 Apr;161(4):355-64Oncothermia: a new paradigm and promising method in cancer therapies
/in Hyperthermia, International Publications /von 2013-01-01 / Acupunct Electrother Res 2013;38(3-4):161-97Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2013-01-01 / Oncoimmunology 2013 Jan;2(1):e22664
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution